# FDA recall D-1324-2022

> **Mckesson Medical-Surgical Inc. Corporate Office** · Class II · drug recall initiated 2022-06-29.

## Product

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

## Reason for recall

CGMP Deviations: products were stored outside the drug label specifications.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-1324-2022
- **Recalling firm:** Mckesson Medical-Surgical Inc. Corporate Office
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-06-29
- **Report date:** 2022-08-17
- **Termination date:** 2024-02-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Richmond, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1324-2022

## Citation

> AI Analytics. FDA recall D-1324-2022. Retrieved 2026-07-09 from https://api.ai-analytics.org/recall/D-1324-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*